Apogee Therapeutics Inc. (NASDAQ:APGE – Get Free Report) CEO Michael Thomas Henderson sold 20,000 shares of the business’s stock in a transaction dated Wednesday, April 8th. The stock was sold at an average price of $82.58, for a total transaction of $1,651,600.00. Following the transaction, the chief executive officer owned 1,132,987 shares in the company, […]

Beam Therapeutics Inc. (NASDAQ:BEAM – Get Free Report) CEO John Evans sold 30,078 shares of the company’s stock in a transaction dated Wednesday, April 1st. The stock was sold at an average price of $24.58, for a total value of $739,317.24. Following the completion of the transaction, the chief executive officer owned 1,047,205 shares in […]

Beam Therapeutics Inc. (NASDAQ:BEAM – Get Free Report) President Giuseppe Ciaramella sold 11,810 shares of the company’s stock in a transaction that occurred on Wednesday, April 1st. The shares were sold at an average price of $24.58, for a total value of $290,289.80. Following the completion of the sale, the president owned 218,406 shares in […]

PTC Therapeutics, Inc. (NASDAQ:PTCT – Get Free Report) EVP Lee Scott Golden sold 829 shares of the stock in a transaction on Thursday, April 2nd. The stock was sold at an average price of $67.99, for a total value of $56,363.71. Following the transaction, the executive vice president directly owned 79,115 shares in the company, […]

ADC Therapeutics SA (NYSE:ADCT – Get Free Report) major shareholder Redmile Group, Llc sold 169,265 shares of ADC Therapeutics stock in a transaction dated Wednesday, April 1st. The stock was sold at an average price of $3.80, for a total value of $643,207.00. Following the transaction, the insider owned 15,301,237 shares of the company’s stock, […]